Mamoon Ur Rashid

Mamoon Ur Rashid

Auto-generated profile, based on publicly available information

Mamoon Ur Rashid

Department of Gastroenterology, Cleveland Clinic, Weston, FL, United States

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Korean Circulation Journal
Verified
Journal Article
Open access
WUWaqas Ullah
Waqas Ullah
MMMaryam Mukhtar
Maryam Mukhtar
HAHafez Abdullah
Hafez Abdullah
MRMamoon Ur Rashid
Mamoon Ur Rashid
AAAsrar Ahmad
Asrar Ahmad
VFVincent M. Figueredo
Vincent M. Figueredo
Ullah W, et al. Korean Circ J. 2018 Aug;49:e63. https://doi.org/10.4070/kcj.2018.0429

2 January 2020 in Journal of Community Hospital Internal Medicine Perspectives
Verified
Journal Article
Open access
YZYousuf Zafar
Yousuf Zafar
YSyasar sattar
yasar sattar
WUWaqas Ullah
Waqas Ullah
SRSohaib Roomi
Sohaib Roomi
MRMamoon-Ur- Rashid
Mamoon-Ur- Rashid
LSLaura Schmidt
Laura Schmidt
Background: Proprotein convertase subtilisin/Kexin type 9 (PCSK-9) inhibitors induced liver dysfunction in patients with or without previous liver injury, and this is not well discussed in the previous literature. Methods: A total sample of 202 patients were retrospectively reviewed at the University of Missouri, Kansas City, from the year 2015 to 2018 based on predefined selection criteria. Inclusion criteria involved patients with dyslipidemia, with or without PCSK-9 inhibitors, liver function tests and lipid profile at baseline and at a mean of 6-month follow-up. The variables, including age, gender, and confounding factors like other medications (statin, oral antidiabetic, and antihypertensive) induced, or chronic secondary liver diseases causing liver injury were taken into consideration. Exclusion criteria included patients without dyslipidemia. Results: The mean age of the study population was 64 ± 11 years (63% males and 37% females). The lipid profile including triglyceride and cholesterol levels during 6-month follow-up visit showed a mean of 184 ± 260 and 163 ± 50 mg/dL as compared to that at baseline of 227 ± 603 and 181 ± 70 mg/dL, respectively. In terms of clinical efficacy, a 6-month follows-up showed a drop in triglyceride and cholesterol levels by 38 and 15 mg/dL, respectively. A liver function test at 6 months in patients taking PCSK-9 inhibitors showed an increase in alanine transaminase (ALT) and aspartate transaminase (AST) by 5.8 mg/dL (p = 0.037) and 6.2 mg/dL (p = 0.008), respectively, from baseline values. Conclusion: PCSK-9 inhibitors should be used cautiously with a follow-up liver function test.

3 March 2020 in Journal of Community Hospital Internal Medicine Perspectives
Verified
Journal Article
Open access
WUWaqas Ullah
Waqas Ullah
MCMuhammad Arslan Cheema
Muhammad Arslan Cheema
AAAmmar Ashfaq
Ammar Ashfaq
MMMaryam Mukhtar
Maryam Mukhtar
ZAZain Ali
Zain Ali
VFVincent Figueredo
Vincent Figueredo
Neuroleptic malignant syndrome is a potentially fatal neurological condition secondary to antipsychotic medication. It is characterized by distinctive clinical findings and autonomic disturbances. NMS has not been associated with Takotsubo cardiomyopathy (TCM). TCM is an abnormal response to physiological stressors resulting from the autonomic abnormalities which at times can mimic myocardial infarction (MI). We present a unique case of a 54-year-old female with bipolar disease presenting with lithium and haloperidol-induced NMS complicated by TCM. The purpose of this case is to make clinicians aware of this rare association.

14 October 2019 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
YZYousaf Zafar
Yousaf Zafar
LMLaura Meidl
Laura Meidl
MLMaddison Lonney
Maddison Lonney
WUWaqas Ullah
Waqas Ullah
MRMamoon Ur Rashid
Mamoon Ur Rashid
We describe the case of a 49-year-old man who presented with a 6-day history of epigastric abdominal pain radiating to his right shoulder which started suddenly after swinging a golf club. A CT angiography of the abdomen was performed which showed dissection of the coeliac trunk extending into the splenic artery and splenic infarct. Anticoagulation was initially started but discontinued due to a small retroperitoneal haemorrhage. The patient remained stable and was discharged on aspirin 325 mg for 1 month followed by aspirin 81 mg. We present this case as well as a review of previously reported cases of splenic infarct due to spontaneous coeliac trunk dissection with the treatments employed as well as the outcomes.

13 August 2021
Verified
Book Chapter
Closed access
DSDeepika Sarvepalli
Deepika Sarvepalli
MRMamoon Ur Rashid
Mamoon Ur Rashid
HZHammad Zafar
Hammad Zafar
SJSundas Jehanzeb
Sundas Jehanzeb
EZEffa Zahid
Effa Zahid
Sarfraz AhmadSarfraz Ahmad
Sarfraz Ahmad

15 May 2020 in Cureus
Verified
Journal Article
Open access
PDF file
BMBayarmaa Mandzhieva
Bayarmaa Mandzhieva
JTJohn Taylor
John Taylor
HZHammad Zafar
Hammad Zafar
MRMamoon Ur Rashid
Mamoon Ur Rashid
AKAbu H. Khan
Abu H. Khan
There are various etiologies of colonic injury and inflammation. The most commonly described colitides in clinical practice are associated with infection, inflammatory bowel disease, ischemia, radiation and medications. The colonic wall has a limited set of responses to different types of injury; therefore, there is overlap between many of these disorders. Focal active colitis is characterized by isolated neutrophilic cryptitis with the background mucosa displaying normal crypt architecture. This inflammatory pattern can be easily unnoticed by pathologists because on low-power examination the mucosa may have almost normal appearance. General practitioners also may not be familiar with this term, underlying etiologies, associated risk factors, course, available therapies and follow up. We present a case of an 82-year-old female with chronic diarrhea and weight loss. She had a negative infectious workup and normal radiology series. She subsequently underwent endoscopic evaluation in lieu of persistent and debilitating symptoms which revealed nonspecific macroscopic findings with pathology noting focal active colitis. She was empirically treated with a 14-day course of Xifaxan and responded well to management with almost complete resolution of her symptoms and no recurrence on six-month follow-up.